Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
MARSHALL WACE LLP | 08-14-2023 | 06-30-2023 | 3400 | 51,204,969,009 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
SYLVAMO CORP | COMMON STOCK | 1551 | $7,782,621 | 192,401 | 0.00 | 0.00 | 17,499 | 10.01 | 06-30-2023 |
ACRIVON THERAPEU | COMMON STOCK | 1552 | $7,743,198 | 597,469 | 0.00 | 0.00 | 0 | 0.00 | 06-30-2023 |
CENTENE CORP | COMMON STOCK | 1553 | $7,729,702 | 114,599 | 0.00 | 114,599 | +Inf | 06-30-2023 | |
SHIFT4 PAYMENT-A | COMMON STOCK | 1554 | $7,714,305 | 113,596 | 0.00 | 0.00 | -467,407 | -80.45 | 06-30-2023 |